| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Attention Deficit Disorder with Hyperactivity | 213 | 2025 | 298 | 38.820 |
Why?
|
| Central Nervous System Stimulants | 66 | 2024 | 180 | 13.380 |
Why?
|
| Behavior Therapy | 56 | 2024 | 180 | 10.670 |
Why?
|
| Methylphenidate | 49 | 2023 | 56 | 10.050 |
Why?
|
| Child | 221 | 2026 | 3443 | 8.220 |
Why?
|
| Parents | 47 | 2026 | 370 | 7.780 |
Why?
|
| Parent-Child Relations | 23 | 2026 | 127 | 7.480 |
Why?
|
| Parenting | 32 | 2026 | 137 | 7.410 |
Why?
|
| Adolescent | 129 | 2026 | 6081 | 4.820 |
Why?
|
| Substance-Related Disorders | 20 | 2025 | 830 | 4.560 |
Why?
|
| Humans | 272 | 2026 | 43102 | 3.450 |
Why?
|
| Male | 206 | 2026 | 23409 | 3.300 |
Why?
|
| Conduct Disorder | 24 | 2024 | 54 | 2.990 |
Why?
|
| Female | 185 | 2026 | 24698 | 2.930 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 24 | 2024 | 55 | 2.850 |
Why?
|
| Child, Preschool | 58 | 2025 | 1546 | 2.510 |
Why?
|
| Adolescent Behavior | 12 | 2024 | 281 | 2.460 |
Why?
|
| Longitudinal Studies | 43 | 2025 | 1063 | 2.320 |
Why?
|
| Child Behavior Disorders | 12 | 2020 | 35 | 2.300 |
Why?
|
| Depression | 13 | 2025 | 863 | 2.130 |
Why?
|
| Treatment Outcome | 50 | 2022 | 1604 | 2.120 |
Why?
|
| Schools | 19 | 2024 | 283 | 2.030 |
Why?
|
| Cognition | 13 | 2024 | 473 | 1.960 |
Why?
|
| Child Behavior | 17 | 2021 | 81 | 1.950 |
Why?
|
| Alcohol Drinking | 13 | 2025 | 609 | 1.860 |
Why?
|
| Mothers | 10 | 2022 | 215 | 1.850 |
Why?
|
| Peer Group | 16 | 2024 | 177 | 1.840 |
Why?
|
| Caregivers | 8 | 2024 | 197 | 1.830 |
Why?
|
| Psychiatric Status Rating Scales | 19 | 2022 | 282 | 1.750 |
Why?
|
| Child of Impaired Parents | 8 | 2024 | 20 | 1.670 |
Why?
|
| Memory, Short-Term | 9 | 2024 | 59 | 1.630 |
Why?
|
| Social Behavior | 19 | 2020 | 161 | 1.600 |
Why?
|
| Marijuana Abuse | 3 | 2026 | 100 | 1.530 |
Why?
|
| Executive Function | 4 | 2022 | 59 | 1.480 |
Why?
|
| Juvenile Delinquency | 7 | 2020 | 44 | 1.460 |
Why?
|
| Adult | 68 | 2026 | 13872 | 1.420 |
Why?
|
| Automobile Driving | 4 | 2016 | 25 | 1.410 |
Why?
|
| Psychotherapy, Group | 4 | 2015 | 23 | 1.400 |
Why?
|
| Combined Modality Therapy | 28 | 2020 | 173 | 1.330 |
Why?
|
| Self Concept | 10 | 2022 | 171 | 1.310 |
Why?
|
| Education, Special | 4 | 2025 | 12 | 1.300 |
Why?
|
| Mass Screening | 5 | 2024 | 541 | 1.290 |
Why?
|
| Emotions | 6 | 2024 | 254 | 1.260 |
Why?
|
| Students | 5 | 2024 | 626 | 1.230 |
Why?
|
| Interpersonal Relations | 11 | 2017 | 222 | 1.220 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 16 | 2016 | 116 | 1.120 |
Why?
|
| Alcoholism | 9 | 2020 | 305 | 1.100 |
Why?
|
| Cost of Illness | 3 | 2019 | 98 | 1.080 |
Why?
|
| Young Adult | 29 | 2026 | 5080 | 1.060 |
Why?
|
| Prospective Studies | 14 | 2025 | 1600 | 1.040 |
Why?
|
| Anxiety | 5 | 2025 | 874 | 1.020 |
Why?
|
| Comorbidity | 21 | 2025 | 737 | 1.010 |
Why?
|
| Family Therapy | 3 | 2016 | 24 | 1.000 |
Why?
|
| Family | 6 | 2019 | 195 | 0.970 |
Why?
|
| Double-Blind Method | 20 | 2022 | 317 | 0.950 |
Why?
|
| Mood Disorders | 3 | 2016 | 54 | 0.930 |
Why?
|
| Achievement | 7 | 2022 | 24 | 0.920 |
Why?
|
| Mental Disorders | 4 | 2022 | 392 | 0.880 |
Why?
|
| Coercion | 1 | 2024 | 11 | 0.870 |
Why?
|
| Child Development | 8 | 2017 | 99 | 0.850 |
Why?
|
| Geographic Information Systems | 1 | 2024 | 47 | 0.850 |
Why?
|
| Body Height | 2 | 2021 | 53 | 0.810 |
Why?
|
| Depressive Disorder | 4 | 2020 | 187 | 0.810 |
Why?
|
| Impulsive Behavior | 4 | 2021 | 55 | 0.780 |
Why?
|
| Employment | 3 | 2019 | 86 | 0.780 |
Why?
|
| Cohort Studies | 12 | 2024 | 1759 | 0.760 |
Why?
|
| Body Weight | 2 | 2021 | 429 | 0.750 |
Why?
|
| Empathy | 4 | 2020 | 33 | 0.730 |
Why?
|
| Language | 2 | 2023 | 185 | 0.730 |
Why?
|
| Linear Models | 2 | 2022 | 317 | 0.720 |
Why?
|
| Pennsylvania | 13 | 2021 | 43 | 0.720 |
Why?
|
| Stress, Psychological | 7 | 2025 | 661 | 0.720 |
Why?
|
| Friends | 3 | 2017 | 25 | 0.720 |
Why?
|
| Severity of Illness Index | 15 | 2019 | 719 | 0.700 |
Why?
|
| Models, Psychological | 8 | 2021 | 140 | 0.690 |
Why?
|
| Time Perception | 1 | 2021 | 9 | 0.680 |
Why?
|
| Psychomotor Performance | 4 | 2019 | 159 | 0.680 |
Why?
|
| Education, Distance | 1 | 2021 | 46 | 0.680 |
Why?
|
| Family Relations | 3 | 2017 | 46 | 0.670 |
Why?
|
| Antisocial Personality Disorder | 5 | 2016 | 20 | 0.670 |
Why?
|
| Attention | 10 | 2022 | 174 | 0.650 |
Why?
|
| Cognition Disorders | 4 | 2020 | 243 | 0.640 |
Why?
|
| Father-Child Relations | 6 | 2019 | 14 | 0.640 |
Why?
|
| Body Mass Index | 2 | 2021 | 925 | 0.640 |
Why?
|
| Reward | 3 | 2020 | 112 | 0.630 |
Why?
|
| Adolescent Development | 4 | 2024 | 40 | 0.620 |
Why?
|
| Sports | 2 | 2017 | 55 | 0.580 |
Why?
|
| Income | 1 | 2019 | 160 | 0.580 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2024 | 989 | 0.570 |
Why?
|
| Parasympathetic Nervous System | 1 | 2018 | 8 | 0.570 |
Why?
|
| Educational Status | 9 | 2016 | 339 | 0.560 |
Why?
|
| Prevalence | 10 | 2026 | 1612 | 0.560 |
Why?
|
| Follow-Up Studies | 26 | 2020 | 1067 | 0.550 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2025 | 568 | 0.550 |
Why?
|
| Quality of Life | 2 | 2022 | 616 | 0.540 |
Why?
|
| Mother-Child Relations | 9 | 2012 | 64 | 0.530 |
Why?
|
| Aggression | 7 | 2011 | 102 | 0.520 |
Why?
|
| United States | 12 | 2026 | 5205 | 0.510 |
Why?
|
| Patient Preference | 2 | 2015 | 60 | 0.510 |
Why?
|
| Dose-Response Relationship, Drug | 13 | 2018 | 1124 | 0.500 |
Why?
|
| Cross-Over Studies | 6 | 2022 | 115 | 0.500 |
Why?
|
| Financing, Personal | 1 | 2016 | 9 | 0.500 |
Why?
|
| Risk-Taking | 4 | 2015 | 457 | 0.500 |
Why?
|
| Pilot Projects | 8 | 2024 | 760 | 0.500 |
Why?
|
| Human Development | 1 | 2016 | 9 | 0.490 |
Why?
|
| School Health Services | 3 | 2005 | 90 | 0.480 |
Why?
|
| Models, Theoretical | 1 | 2017 | 232 | 0.480 |
Why?
|
| Independent Living | 1 | 2016 | 47 | 0.480 |
Why?
|
| Evidence-Based Practice | 2 | 2020 | 50 | 0.470 |
Why?
|
| Social Adjustment | 6 | 2011 | 30 | 0.460 |
Why?
|
| Dextroamphetamine | 2 | 2014 | 9 | 0.460 |
Why?
|
| Randomized Controlled Trials as Topic | 6 | 2016 | 375 | 0.460 |
Why?
|
| Risk Factors | 16 | 2022 | 3994 | 0.460 |
Why?
|
| Cost-Benefit Analysis | 2 | 2016 | 179 | 0.460 |
Why?
|
| Fathers | 5 | 2019 | 38 | 0.440 |
Why?
|
| Neuropsychological Tests | 8 | 2021 | 284 | 0.440 |
Why?
|
| Drug Administration Schedule | 7 | 2016 | 153 | 0.440 |
Why?
|
| Social Perception | 4 | 2016 | 72 | 0.440 |
Why?
|
| Propylamines | 2 | 2011 | 5 | 0.420 |
Why?
|
| Delayed-Action Preparations | 3 | 2021 | 74 | 0.410 |
Why?
|
| Evidence-Based Medicine | 2 | 2005 | 107 | 0.410 |
Why?
|
| Illusions | 3 | 2008 | 4 | 0.400 |
Why?
|
| Mental Health | 5 | 2025 | 385 | 0.400 |
Why?
|
| Social Environment | 6 | 2011 | 218 | 0.400 |
Why?
|
| Personality | 3 | 2020 | 55 | 0.390 |
Why?
|
| Video Recording | 2 | 2011 | 41 | 0.370 |
Why?
|
| Punishment | 2 | 2024 | 9 | 0.360 |
Why?
|
| Analysis of Variance | 7 | 2016 | 575 | 0.360 |
Why?
|
| Family Conflict | 3 | 2012 | 13 | 0.360 |
Why?
|
| Music | 2 | 2011 | 28 | 0.360 |
Why?
|
| Reproducibility of Results | 13 | 2022 | 1081 | 0.350 |
Why?
|
| Personality Assessment | 13 | 2008 | 45 | 0.350 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2011 | 4 | 0.340 |
Why?
|
| Internal-External Control | 7 | 2008 | 63 | 0.340 |
Why?
|
| Program Development | 4 | 2009 | 240 | 0.340 |
Why?
|
| Case-Control Studies | 9 | 2019 | 1285 | 0.330 |
Why?
|
| Patient Education as Topic | 2 | 2012 | 235 | 0.330 |
Why?
|
| Memory Disorders | 3 | 2021 | 77 | 0.320 |
Why?
|
| Health Care Costs | 3 | 2007 | 91 | 0.320 |
Why?
|
| Pediatrics | 2 | 2020 | 70 | 0.300 |
Why?
|
| Factor Analysis, Statistical | 2 | 2021 | 162 | 0.290 |
Why?
|
| Deception | 2 | 2019 | 7 | 0.290 |
Why?
|
| Mental Health Services | 2 | 2015 | 141 | 0.280 |
Why?
|
| Alcohol-Related Disorders | 2 | 2021 | 63 | 0.280 |
Why?
|
| Motivation | 3 | 2024 | 513 | 0.280 |
Why?
|
| Prognosis | 6 | 2019 | 861 | 0.280 |
Why?
|
| Loneliness | 2 | 2007 | 24 | 0.260 |
Why?
|
| Adaptation, Psychological | 7 | 2022 | 420 | 0.260 |
Why?
|
| Middle Ear Ventilation | 1 | 2007 | 1 | 0.260 |
Why?
|
| Otitis Media with Effusion | 1 | 2007 | 1 | 0.260 |
Why?
|
| Logistic Models | 2 | 2020 | 1009 | 0.250 |
Why?
|
| Single Parent | 3 | 2012 | 5 | 0.240 |
Why?
|
| Teaching | 3 | 2008 | 59 | 0.240 |
Why?
|
| Child Rearing | 2 | 2019 | 9 | 0.230 |
Why?
|
| Research Design | 3 | 2017 | 385 | 0.230 |
Why?
|
| Tobacco Use Disorder | 2 | 2021 | 250 | 0.230 |
Why?
|
| Middle Aged | 7 | 2026 | 12222 | 0.230 |
Why?
|
| Interview, Psychological | 4 | 2016 | 63 | 0.230 |
Why?
|
| Socialization | 3 | 2019 | 23 | 0.230 |
Why?
|
| Monte Carlo Method | 2 | 2022 | 64 | 0.230 |
Why?
|
| Nicotine | 3 | 2024 | 302 | 0.230 |
Why?
|
| Hair | 1 | 2025 | 38 | 0.220 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 3 | 2011 | 59 | 0.220 |
Why?
|
| Actigraphy | 2 | 2024 | 17 | 0.220 |
Why?
|
| Videoconferencing | 1 | 2024 | 5 | 0.220 |
Why?
|
| Task Performance and Analysis | 3 | 2022 | 47 | 0.220 |
Why?
|
| Assertiveness | 3 | 2009 | 7 | 0.220 |
Why?
|
| Telephone | 1 | 2024 | 36 | 0.210 |
Why?
|
| Medication Adherence | 2 | 2016 | 182 | 0.210 |
Why?
|
| Health Surveys | 1 | 2026 | 405 | 0.210 |
Why?
|
| Sensitivity and Specificity | 3 | 2022 | 611 | 0.210 |
Why?
|
| Cannabinoids | 1 | 2025 | 73 | 0.210 |
Why?
|
| Marijuana Smoking | 2 | 2015 | 91 | 0.200 |
Why?
|
| Statistics as Topic | 3 | 2015 | 123 | 0.200 |
Why?
|
| Attitude | 2 | 2021 | 108 | 0.200 |
Why?
|
| Opiate Alkaloids | 1 | 2023 | 8 | 0.200 |
Why?
|
| Models, Statistical | 1 | 2024 | 195 | 0.190 |
Why?
|
| Infant | 3 | 2022 | 1175 | 0.190 |
Why?
|
| Administration, Cutaneous | 3 | 2010 | 48 | 0.190 |
Why?
|
| Smoking | 4 | 2016 | 1024 | 0.190 |
Why?
|
| Programming Languages | 1 | 2022 | 29 | 0.190 |
Why?
|
| Risk | 5 | 2016 | 287 | 0.190 |
Why?
|
| Regression Analysis | 7 | 2013 | 490 | 0.190 |
Why?
|
| Referral and Consultation | 3 | 2016 | 142 | 0.180 |
Why?
|
| Algorithms | 4 | 2020 | 509 | 0.180 |
Why?
|
| Reference Values | 1 | 2022 | 211 | 0.180 |
Why?
|
| Appetite | 1 | 2021 | 21 | 0.180 |
Why?
|
| Classification | 1 | 2021 | 9 | 0.170 |
Why?
|
| Politics | 1 | 2021 | 42 | 0.170 |
Why?
|
| Psychometrics | 9 | 2021 | 358 | 0.170 |
Why?
|
| Cannabis | 1 | 2023 | 90 | 0.170 |
Why?
|
| Retrospective Studies | 3 | 2019 | 2544 | 0.170 |
Why?
|
| Child Abuse | 1 | 2022 | 92 | 0.170 |
Why?
|
| Disease Progression | 3 | 2019 | 667 | 0.170 |
Why?
|
| Education | 4 | 2009 | 60 | 0.160 |
Why?
|
| Age Factors | 7 | 2018 | 1154 | 0.160 |
Why?
|
| Cross-Sectional Studies | 4 | 2026 | 3156 | 0.160 |
Why?
|
| House Calls | 1 | 2020 | 8 | 0.160 |
Why?
|
| Survival Analysis | 2 | 2019 | 368 | 0.160 |
Why?
|
| Curriculum | 1 | 2022 | 318 | 0.150 |
Why?
|
| Insurance Claim Review | 1 | 2019 | 37 | 0.150 |
Why?
|
| Managed Care Programs | 1 | 2019 | 40 | 0.150 |
Why?
|
| Observer Variation | 5 | 2021 | 59 | 0.150 |
Why?
|
| Morals | 1 | 2019 | 15 | 0.150 |
Why?
|
| Violence | 1 | 2020 | 136 | 0.140 |
Why?
|
| Life Change Events | 2 | 2017 | 109 | 0.140 |
Why?
|
| Infant, Newborn | 1 | 2021 | 972 | 0.140 |
Why?
|
| Patient Dropouts | 2 | 2012 | 32 | 0.140 |
Why?
|
| Anger | 2 | 2016 | 27 | 0.140 |
Why?
|
| Adrenergic alpha-Agonists | 2 | 2008 | 32 | 0.140 |
Why?
|
| Clonidine | 2 | 2008 | 50 | 0.140 |
Why?
|
| Law Enforcement | 1 | 2017 | 14 | 0.140 |
Why?
|
| Computer Simulation | 2 | 2021 | 408 | 0.140 |
Why?
|
| Affect | 3 | 2016 | 180 | 0.140 |
Why?
|
| Negotiating | 1 | 2017 | 27 | 0.130 |
Why?
|
| Seasons | 1 | 2018 | 139 | 0.130 |
Why?
|
| Irritable Mood | 1 | 2016 | 2 | 0.130 |
Why?
|
| Communication Disorders | 1 | 2016 | 8 | 0.130 |
Why?
|
| Language Tests | 1 | 2016 | 23 | 0.130 |
Why?
|
| Social Support | 2 | 2012 | 445 | 0.130 |
Why?
|
| Psychological Tests | 2 | 2007 | 56 | 0.120 |
Why?
|
| Fear | 1 | 2019 | 272 | 0.120 |
Why?
|
| Communication | 3 | 2022 | 210 | 0.120 |
Why?
|
| Foster Home Care | 1 | 2016 | 14 | 0.120 |
Why?
|
| Psychology | 2 | 2007 | 39 | 0.120 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 590 | 0.120 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 165 | 0.110 |
Why?
|
| Spouse Abuse | 2 | 2014 | 52 | 0.110 |
Why?
|
| Reaction Time | 4 | 2009 | 157 | 0.110 |
Why?
|
| Polymorphism, Genetic | 3 | 2011 | 201 | 0.110 |
Why?
|
| Medical Records | 1 | 2014 | 48 | 0.110 |
Why?
|
| Mental Recall | 1 | 2014 | 84 | 0.100 |
Why?
|
| Socioeconomic Factors | 7 | 2022 | 1234 | 0.100 |
Why?
|
| Sociometric Techniques | 3 | 2007 | 5 | 0.100 |
Why?
|
| Psychopathology | 1 | 2012 | 20 | 0.100 |
Why?
|
| Sex Factors | 3 | 2013 | 1028 | 0.100 |
Why?
|
| Self Disclosure | 2 | 2010 | 44 | 0.100 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 638 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 49 | 0.090 |
Why?
|
| Individuality | 1 | 2011 | 54 | 0.090 |
Why?
|
| Predictive Value of Tests | 6 | 2007 | 440 | 0.090 |
Why?
|
| Maternal Behavior | 1 | 2011 | 29 | 0.080 |
Why?
|
| Dysthymic Disorder | 1 | 2010 | 3 | 0.080 |
Why?
|
| Time Factors | 6 | 2014 | 1857 | 0.080 |
Why?
|
| Baseball | 1 | 1990 | 2 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 4 | 2012 | 125 | 0.080 |
Why?
|
| Aged | 1 | 2022 | 8214 | 0.080 |
Why?
|
| Program Evaluation | 2 | 2008 | 359 | 0.080 |
Why?
|
| Forecasting | 2 | 2013 | 136 | 0.070 |
Why?
|
| Suicide, Attempted | 1 | 2010 | 108 | 0.070 |
Why?
|
| Divorce | 1 | 2008 | 7 | 0.070 |
Why?
|
| Drug Monitoring | 1 | 2009 | 69 | 0.070 |
Why?
|
| Receptors, Dopamine D2 | 1 | 2009 | 83 | 0.070 |
Why?
|
| Personal Construct Theory | 1 | 2008 | 1 | 0.070 |
Why?
|
| Socioenvironmental Therapy | 1 | 2008 | 1 | 0.070 |
Why?
|
| Token Economy | 1 | 2008 | 1 | 0.070 |
Why?
|
| Saliva | 1 | 2009 | 119 | 0.070 |
Why?
|
| Space Perception | 1 | 2008 | 35 | 0.070 |
Why?
|
| ROC Curve | 1 | 2008 | 159 | 0.070 |
Why?
|
| Eating | 1 | 2009 | 167 | 0.070 |
Why?
|
| Models, Econometric | 1 | 2007 | 4 | 0.070 |
Why?
|
| Social Problems | 1 | 2007 | 14 | 0.070 |
Why?
|
| Visual Perception | 1 | 2008 | 80 | 0.070 |
Why?
|
| Hierarchy, Social | 1 | 2007 | 9 | 0.070 |
Why?
|
| Cues | 1 | 2008 | 81 | 0.070 |
Why?
|
| Defense Mechanisms | 1 | 2006 | 10 | 0.060 |
Why?
|
| Aptitude | 1 | 2006 | 7 | 0.060 |
Why?
|
| Object Attachment | 1 | 2007 | 28 | 0.060 |
Why?
|
| Electrocardiography | 1 | 2008 | 185 | 0.060 |
Why?
|
| Culture | 1 | 2008 | 172 | 0.060 |
Why?
|
| Patient Compliance | 2 | 2010 | 233 | 0.060 |
Why?
|
| Hyperkinesis | 1 | 2006 | 7 | 0.060 |
Why?
|
| International Classification of Diseases | 1 | 2006 | 27 | 0.060 |
Why?
|
| Public Sector | 1 | 2005 | 18 | 0.060 |
Why?
|
| Problem Solving | 3 | 2009 | 38 | 0.060 |
Why?
|
| Health Education | 1 | 2009 | 363 | 0.060 |
Why?
|
| Early Diagnosis | 2 | 2019 | 68 | 0.060 |
Why?
|
| Minisatellite Repeats | 3 | 2011 | 18 | 0.060 |
Why?
|
| Behavior | 1 | 2005 | 35 | 0.060 |
Why?
|
| Cannabidiol | 1 | 2025 | 10 | 0.060 |
Why?
|
| Personal Satisfaction | 1 | 2005 | 76 | 0.060 |
Why?
|
| Heart Rate | 3 | 2008 | 266 | 0.060 |
Why?
|
| Costs and Cost Analysis | 2 | 2020 | 60 | 0.060 |
Why?
|
| Drug Utilization | 1 | 2004 | 34 | 0.060 |
Why?
|
| Faculty | 3 | 2011 | 105 | 0.050 |
Why?
|
| Mental Competency | 1 | 2004 | 12 | 0.050 |
Why?
|
| Interviews as Topic | 2 | 2020 | 452 | 0.050 |
Why?
|
| Age of Onset | 2 | 2016 | 114 | 0.050 |
Why?
|
| Data Collection | 1 | 2004 | 210 | 0.050 |
Why?
|
| Pitch Discrimination | 1 | 2002 | 4 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2023 | 31 | 0.050 |
Why?
|
| Choice Behavior | 3 | 2009 | 93 | 0.050 |
Why?
|
| Emergency Services, Psychiatric | 1 | 2002 | 9 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 1 | 2002 | 61 | 0.050 |
Why?
|
| Genotype | 3 | 2011 | 800 | 0.050 |
Why?
|
| Affective Symptoms | 1 | 2002 | 63 | 0.050 |
Why?
|
| Vulnerable Populations | 1 | 2003 | 166 | 0.050 |
Why?
|
| North Carolina | 1 | 2022 | 127 | 0.050 |
Why?
|
| Bipolar Disorder | 1 | 2003 | 84 | 0.050 |
Why?
|
| Guidelines as Topic | 1 | 2002 | 56 | 0.050 |
Why?
|
| Police | 1 | 2021 | 17 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 182 | 0.040 |
Why?
|
| Blinking | 3 | 2010 | 14 | 0.040 |
Why?
|
| Sexual Behavior | 1 | 2006 | 638 | 0.040 |
Why?
|
| Chicago | 2 | 2014 | 31 | 0.040 |
Why?
|
| Sleep | 1 | 2023 | 185 | 0.040 |
Why?
|
| Social Desirability | 3 | 2007 | 6 | 0.040 |
Why?
|
| Efferent Pathways | 1 | 2020 | 16 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 241 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2020 | 21 | 0.040 |
Why?
|
| Reinforcement Schedule | 2 | 2009 | 15 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2020 | 98 | 0.040 |
Why?
|
| Activities of Daily Living | 2 | 2010 | 139 | 0.040 |
Why?
|
| Education, Nonprofessional | 1 | 2019 | 1 | 0.040 |
Why?
|
| Anxiety Disorders | 3 | 2010 | 322 | 0.040 |
Why?
|
| New York | 2 | 2009 | 93 | 0.040 |
Why?
|
| Exercise | 1 | 2025 | 692 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 152 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2020 | 341 | 0.040 |
Why?
|
| Motor Skills | 2 | 2014 | 46 | 0.030 |
Why?
|
| Community Mental Health Services | 2 | 2010 | 34 | 0.030 |
Why?
|
| Counseling | 2 | 2008 | 138 | 0.030 |
Why?
|
| Aftercare | 1 | 2017 | 22 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 587 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2010 | 236 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2020 | 574 | 0.030 |
Why?
|
| Electromyography | 2 | 2010 | 69 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2020 | 380 | 0.030 |
Why?
|
| Autistic Disorder | 1 | 2015 | 39 | 0.030 |
Why?
|
| Sex Distribution | 2 | 2006 | 224 | 0.030 |
Why?
|
| Athletic Performance | 1 | 2014 | 26 | 0.030 |
Why?
|
| Vocational Guidance | 1 | 2013 | 2 | 0.020 |
Why?
|
| Behavioral Sciences | 1 | 2012 | 2 | 0.020 |
Why?
|
| Social Sciences | 1 | 2012 | 6 | 0.020 |
Why?
|
| Random Allocation | 2 | 2003 | 147 | 0.020 |
Why?
|
| Arousal | 2 | 2002 | 95 | 0.020 |
Why?
|
| Waiting Lists | 1 | 2012 | 38 | 0.020 |
Why?
|
| Marital Status | 1 | 2011 | 46 | 0.020 |
Why?
|
| Women | 1 | 2010 | 28 | 0.020 |
Why?
|
| Intention to Treat Analysis | 1 | 2010 | 14 | 0.020 |
Why?
|
| Intelligence Tests | 1 | 2009 | 8 | 0.020 |
Why?
|
| Alleles | 1 | 2011 | 352 | 0.020 |
Why?
|
| Nova Scotia | 1 | 2009 | 7 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2016 | 590 | 0.020 |
Why?
|
| Behavioral Symptoms | 1 | 2009 | 7 | 0.020 |
Why?
|
| Placebo Effect | 1 | 2009 | 14 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 518 | 0.020 |
Why?
|
| Placebos | 1 | 2009 | 41 | 0.020 |
Why?
|
| Americas | 1 | 2009 | 5 | 0.020 |
Why?
|
| Control Groups | 1 | 2008 | 2 | 0.020 |
Why?
|
| Paternal Behavior | 1 | 2008 | 5 | 0.020 |
Why?
|
| Suicide | 1 | 2010 | 140 | 0.020 |
Why?
|
| Weight Loss | 1 | 2009 | 137 | 0.020 |
Why?
|
| Bradycardia | 1 | 2008 | 9 | 0.020 |
Why?
|
| Sleep Stages | 1 | 2008 | 7 | 0.020 |
Why?
|
| Reinforcement, Social | 1 | 2008 | 3 | 0.020 |
Why?
|
| Tachycardia | 1 | 2008 | 11 | 0.020 |
Why?
|
| Japan | 1 | 2009 | 348 | 0.020 |
Why?
|
| Long QT Syndrome | 1 | 2008 | 15 | 0.020 |
Why?
|
| Single-Parent Family | 1 | 2007 | 5 | 0.020 |
Why?
|
| National Institute of Mental Health (U.S.) | 1 | 2007 | 4 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 150 | 0.020 |
Why?
|
| Camping | 1 | 2007 | 1 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 62 | 0.020 |
Why?
|
| Helping Behavior | 1 | 2007 | 6 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 234 | 0.020 |
Why?
|
| Social Conformity | 1 | 2007 | 15 | 0.020 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 277 | 0.020 |
Why?
|
| Dopamine | 1 | 2009 | 275 | 0.020 |
Why?
|
| Discrimination Learning | 1 | 2006 | 38 | 0.020 |
Why?
|
| Discriminant Analysis | 1 | 2006 | 25 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2007 | 206 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2006 | 36 | 0.020 |
Why?
|
| Health Expenditures | 1 | 2007 | 44 | 0.020 |
Why?
|
| Pemoline | 1 | 2006 | 1 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2007 | 259 | 0.020 |
Why?
|
| Maze Learning | 1 | 2006 | 113 | 0.020 |
Why?
|
| Normal Distribution | 1 | 2006 | 14 | 0.020 |
Why?
|
| Amphetamine | 1 | 2006 | 21 | 0.020 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2005 | 12 | 0.010 |
Why?
|
| Drug Costs | 1 | 2005 | 35 | 0.010 |
Why?
|
| Focus Groups | 1 | 2007 | 423 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 863 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2006 | 587 | 0.010 |
Why?
|
| Demography | 1 | 2005 | 195 | 0.010 |
Why?
|
| Personality Inventory | 1 | 2004 | 82 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2004 | 74 | 0.010 |
Why?
|
| Intelligence | 1 | 2002 | 15 | 0.010 |
Why?
|
| Psychophysiology | 1 | 2002 | 14 | 0.010 |
Why?
|
| Family Health | 1 | 2003 | 55 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2003 | 154 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2002 | 78 | 0.010 |
Why?
|
| Brain | 1 | 2009 | 1472 | 0.010 |
Why?
|
| Circadian Rhythm | 1 | 2003 | 236 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 259 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2002 | 734 | 0.010 |
Why?
|